Mitochondrial matrix K+ flux independent of large-conductance Ca2+-activated K+ channel opening.
Large-conductance Ca(2+)-activated K(+) channels (BK(Ca)) in the inner mitochondrial membrane may play a role in protecting against cardiac ischemia-reperfusion injury. NS1619 (30 microM), an activator of BK(Ca) channels, was shown to increase respiration and to stimulate reactive oxygen species generation in isolated cardiac mitochondria energized with succinate. Here, we tested effects of NS1619 to alter matrix K(+), H(+), and swelling in mitochondria isolated from guinea pig hearts. We found that 30 microM NS1619 did not change matrix K(+), H(+), and swelling, but that 50 and 100 microM NS1619 caused a concentration-dependent increase in matrix K(+) influx (PBFI fluorescence) only when quinine was present to block K(+)/H(+) exchange (KHE); this was accompanied by increased mitochondrial matrix volume (light scattering). Matrix pH (BCECF fluorescence) was decreased slightly by 50 and 100 microM NS1619 but markedly more so when quinine was present. NS1619 (100 microM) caused a significant leak in lipid bilayers, and this was enhanced in the presence of quinine. The K(+) ionophore valinomycin (0.25 nM), which like NS1619 increased matrix volume and increased K(+) influx in the presence of quinine, caused matrix alkalinization followed by acidification when quinine was absent, and only alkalinization when quinine was present. If K(+) is exchanged instantly by H(+) through activated KHE, then matrix K(+) influx should stimulate H(+) influx through KHE and cause matrix acidification. Our results indicate that KHE is not activated immediately by NS1619-induced K(+) influx, that NS1619 induces matrix K(+) and H(+) influx through a nonspecific transport mechanism, and that enhancement with quinine is not due to the blocking of KHE, but to a nonspecific effect of quinine to enhance current leak by NS1619.
Aldakkak
Mohammed
M
M4280, 8701 Watertown Plank Rd., Medical College of Wisconsin, Milwaukee, WI 53226, USA.
Stowe
David F
DF
Cheng
Qunli
Q
Kwok
Wai-Meng
WM
Camara
Amadou K S
AK
D000818:Animals; D001562:Benzimidazoles / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D006168:Guinea Pigs; D006863:Hydrogen-Ion Concentration; D015640:Ion Channel Gating / Q000187:drug effects*; D007700:Kinetics; D051036:Large-Conductance Calcium-Activated Potassium Channels / Q000819:agonists* / Q000037:antagonists & inhibitors / Q000378:metabolism; D008027:Light; D008929:Mitochondria, Heart / Q000187:drug effects* / Q000378:metabolism; D051336:Mitochondrial Membranes / Q000187:drug effects* / Q000378:metabolism; D008933:Mitochondrial Swelling; D011188:Potassium / Q000378:metabolism*; D027961:Potassium-Hydrogen Antiporters / Q000037:antagonists & inhibitors / Q000378:metabolism; D011803:Quinine / Q000494:pharmacology; D012542:Scattering, Radiation; D013053:Spectrophotometry; D014634:Valinomycin / Q000494:pharmacology
D001562:Benzimidazoles; D051036:Large-Conductance Calcium-Activated Potassium Channels; D027961:Potassium-Hydrogen Antiporters; C086491:NS 1619; D014634:Valinomycin; D011803:Quinine; D011188:Potassium